Stockholders' Equity (Deficit) (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2022

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table summarizes the options outstanding at March 31, 2022 and the related prices for the options to purchase shares of the Company’s common stock:

						Weighted				Weighted
				Weighted		average				average
				average		exercise				exercise
Range of		Number of		remaining		price of		Number of		price of
exercise		options		contractual		outstanding		options		exercisable
prices		outstanding		life (years)		options		exercisable		options
$	0.03- 0.39		18,671,211		8.85	$	0.20		6,636,628	$	0.14
			18,671,211		8.85	$	0.20		6,636,628	$	0.14

The following table summarizes the options outstanding at December 31, 2021 and the related prices for the options to purchase shares of the Company’s common stock:

						Weighted				Weighted
				Weighted		average				average
				average		exercise				exercise
Range of		Number of		remaining		price of		Number of		price of
exercise		options		contractual		outstanding		options		exercisable
prices		outstanding		life (years)		options		exercisable		options
$	0.03- 0.39		18,746,211		9.10	$	0.20		5,502,877	$	0.11
			18,746,211		9.10	$	0.20		5,502,877	$	0.11

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

Transactions involving stock options are summarized as follows:

	Shares			Weighted- Average Exercise Price ($) (A)
Outstanding at December 31, 2021		18,746,211		$	0.20
Granted		-		$	-
Expired		(75,000	)		0.03
Outstanding at March 31, 2022		18,671,211		$	0.20
Options vested and exercisable		6,636,628		$	0.14

Transactions involving stock options are summarized as follows:

	Shares			Weighted- Average Exercise Price ($) (A)
Outstanding at January 1, 2020		67,879		$	0.03
Granted		14,886,000			0.03
Cancelled/Expired		(1,500,000	)		0.03
Outstanding at December 31, 2020		13,453,879		$	0.03
Granted		14,295,000		$	0.26
Cancelled/Expired		(350,000	)	$	0.03
Exercised		(8,652,668	)		0.03
Outstanding at December 31, 2021		18,746,211		$	0.20
Options vested and exercisable		5,502,877		$	0.11

(A) On December 14, 2020, the Company reset the exercise price of all the options then outstanding options to $0.03 per share. This included 150,000 options previously priced at $0.04 per share; 7,450,000 options previously priced at $0.05 per share; 1,000,000 options previously priced at $0.06 per share; and 67,879 options previously prices at $21.40 per share. The Company valued these options as of December 14, 2020, at the original exercise price and at the new price of $0.03 per share and charged the increase in value in the amount of $4,113 to operations during the year ended December 31, 2020. The exercise prices of all options are shown at the restated price of $0.03 per share.

(B) On December 28, 2020, the Company accelerated the vesting of certain of its options issued to Board members, management, and consultants, resulting in a charge to operations in the amount of $164,647 during the year ended December 31, 2020.

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The Company did not value any stock options during the three months ended March 31, 2022.  The Company valued stock options during the three months ended March 31,  2021 using the Black-Scholes valuation model utilizing the following variables:

	March 31,			March 31,
	2022			2021
Volatility		-	%		169.3% to 183.5	%
Dividends	$	-		$	-
Risk-free interest rates		-	%		0.82% to 1.69	%
Term (years)		-			2.50 to 10.00

The Company valued stock options during the years ended December 31, 2021 and 2020 using the Black-Scholes valuation model utilizing the following variables:

	December 31,			December 31,
	2021			2020
Volatility		153.5% to 183.5	%		149.4% to 209.6	%
Dividends	$	-		$	-
Risk-free interest rates		0.820% to 1.69	%		0.55% to 1.30	%
Term (years)		5.00-6.5			5.00

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

The following table summarizes the warrants outstanding on March 31, 2022, and the related prices for the warrants to purchase shares of the Company’s common stock:

	Shares		Weighted- Average Exercise Price ($)
Outstanding on December 31, 2021		29,820,000	$	0.625
Granted		1,585,000	$	0.558
Exercised		-	$	-
Outstanding on March 31, 2022		31,405,000	$	0.622

The following table summarizes the warrants outstanding at December 30, 2021 and the related prices for the warrants to purchase shares of the Company’s common stock:

	Shares			Weighted- Average Exercise Price ($)
Outstanding at December 31, 2019		1,800,000		$	0.00858
Granted		6,582,382		$	0.00858
Exercised		(8,382,382	)	$	0.0561
Outstanding at December 31, 2020		-		$	-
Granted		29,820,000		$	0.625
Exercised		-		$	-
Outstanding at December 31, 2021		29,820,000		$	0.625

Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]

The Company valued warrants options during the three months ended March 31,  2022 and 2021 using the Black-Scholes valuation model utilizing the following variables:

	March 31,			March 31,
	2022			2021
Volatility		147.8 to 150.7	%		171.6% to 183.5	%
Dividends	$	-		$	-
Risk-free interest rates		0.76% to 0.83	%		1.15% to 1.63	%
Term (years)		0.25			5.00 to 6.50